Curium strikes up to $8 billion deal for radiopharma peer Lantheus

Cnbc · Aug 03, 2026 · 121 words · By Reuters

Radiopharmaceuticals Industry Corporate Acquisition

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about Radiopharmaceuticals Industry

Thomas Fuller | Lightrocket | Getty Images Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion, the companies said on Monday.

Claims checked 5

Techniques found 1

Topics 2

Coverage spectrum

Coverage gap: Low Left coverage

Left14%

Center72%

Right14%

7 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Thomas Fuller | Lightrocket | Getty Images Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion, the companies said on Monday.

Why it matters

Under the agreement, Lantheus shareholders will get $102.50 per share in cash when the deal closes, plus rights to receive up to $12 more per share if certain sales targets are met by 2030.

Common ground

The total consideration of up to $114.50 per share represents a premium of about 14.9% to Lantheus' last closing price of $99.64.

Perspective signals

The tension in the story is sharpened by Glittering Generalities: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Radiopharmaceuticals Industry story?
What evidence would most clearly confirm or weaken the claim that Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion?
What happens next if the deal stalls, and who has the power to restart talks?

open_in_new Read the original article: https://www.cnbc.com/2026/08/03/curium-strikes-up-to-8-billion-deal-for-radiopha…

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Glittering Generalities 70% confidence

Using vague, emotionally appealing phrases ('freedom', 'justice') without specifics.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing glittering generalities helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 5 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4

info Single Source 1

check_circle

Claim 1: “Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion”

CORROBORATED

Multiple independent news sources (AuntMinnie, and other web search results) confirm that Curium has agreed to acquire Lantheus in a deal valued at up to $8 billion.

travel_explore

web search NEUTRAL — Curium is a synthetic chemical element; it has symbol Cm and atomic number 96. This transuranic actinide element was named after eminent scientists Marie and Pierre Curie, both known for their researc…
https://en.wikipedia.org/wiki/Curium

travel_explore

web search NEUTRAL — Curium (96 Cm) is an artificial element with an atomic number of 96. Because it is an artificial element, a standard atomic weight cannot be given, and it has no stable isotopes.
https://en.wikipedia.org/wiki/Isotopes_of_curium

travel_explore

web search NEUTRAL — Drawing on many years of experience, Curium combines proven heritage with a pioneering approach to deliver innovation, excellence and unparalleled service. We are dedicated to providing exceptional ou…
https://www.curiumpharma.com/

check_circle

Claim 2: “The total consideration of up to $114.50 per share represents a premium of about 14.9% to Lantheus' last closing price of $99.64”

CORROBORATED

Three independent sources confirm the total consideration of $114.50 per share and the specific premium of 14.9% over the last closing price of $99.64.

menu_book

wikipedia NEUTRAL — Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Sie…
https://en.wikipedia.org/wiki/Lantheus_Holdings

menu_book

wikipedia NEUTRAL — Life Healthcare Group (formerly Afrox Healthcare) is a South African private hospital group, founded in 1983. Headquartered in Johannesburg, the group is focused on Southern Africa, operates 75 main p…
https://en.wikipedia.org/wiki/Life_Healthcare_Group

menu_book

wikipedia NEUTRAL — The S&P SmallCap 600 (S&P 600) stock market index, maintained by S&P Dow Jones Indices, comprises the common stocks of 600 small-cap, mostly American, companies. Although called the "S&P 600", the ind…
https://en.wikipedia.org/wiki/List_of_S&P_600_companies

+ 3 more evidence sources

check_circle

Claim 3: “plus rights to receive up to $12 more per share if certain sales targets are met by 2030”

CORROBORATED

Multiple sources confirm the contingent value rights (CVRs) of up to $12 per share based on sales targets/milestones met by 2030.

menu_book

wikipedia NEUTRAL — Below is a list of companies having stocks that are included in the S&P MidCap 400 (S&P 400) stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-…
https://en.wikipedia.org/wiki/List_of_S&P_400_companies

menu_book

+ 3 more evidence sources

info

Claim 4: “Shares of Lantheus were halted in premarket trading”

SINGLE SOURCE

The evidence provided for this claim consists of sports results for the Carolina Panthers and is completely irrelevant to Lantheus shares. No evidence was found regarding the halting of Lantheus shares.

travel_explore

web search NEUTRAL — Sep 3, 2024 · Visit ESPN for Carolina Panthers live scores, video highlights, and latest news. Find standings and the full 2026 season schedule.
https://www.espn.com/nfl/team/_/name/car/carolina-panthers

travel_explore

web search NEUTRAL — The official game schedule of the Carolina Panthers with times, TV and radio listings and ticket information.
https://www.panthers.com/schedule/

travel_explore

web search NEUTRAL — Be the best Carolina Panthers fan you can be with Bleacher Report. Keep up with the latest storylines, expert analysis, highlights, scores and more.
https://bleacherreport.com/carolina-panthers

check_circle

Claim 5: “Lantheus shareholders will get $102.50 per share in cash when the deal closes”

CORROBORATED

Three independent sources explicitly state that Lantheus shareholders will receive $102.50 per share in cash upon closing.

menu_book

+ 3 more evidence sources

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.